Recent Finacing
Recent Raise
Clade Therapeutics develops off-the-shelf allogeneic cell therapies, leveraging expertise in human embryonic stem cells under CEO Chad Cowan.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at Clade Therapeutics.
